Prenatal and Postnatal Identification of Phelan–McDermid Syndrome in a Tertiary Referral Center: A 15-Case Series and Literature Review
Open Access
- 14 September 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7130
Abstract
Objectives: To characterize the clinical and genetic features of Phelan–McDermid syndrome (PMS) in a Chinese prenatal and postnatal cohort, explore genotype–phenotype correlations, and provide evidence to support prenatal genetic counseling. Methods: G-banded karyotyping, single-nucleotide polymorphism arrays (SNP arrays), copy number variation sequencing, and trio whole-exome sequencing were used for genetic diagnosis. Fifteen patients with PMS (11 prenatal and 4 postnatal) were retrospectively enrolled. Genomic visualization, protein structural prediction, and phenotypic heatmap analyses were conducted to analyze genotype–phenotype associations. Results: The prenatal and postnatal detection rates of PMS were 0.061% and 0.49%, respectively. Only 13.3% of cases were detected by karyotyping, whereas 14 cases were confirmed by SNP array analysis. All 22q13 deletions (69.4 kb–8.5 Mb) involved SHANK3, and all copy number variants were de novo. A novel SHANK3 frameshift variant, c.3513_3514delCC, was identified and predicted to result in protein truncation leading to intellectual disability. Prenatal cases mainly presented non-specific ultrasound anomalies (63.6%, 7/11), with fetal growth restriction, renal malformations, and cardiovascular defects being the most frequent findings. A notable 36.4% (4/11) of prenatal cases were complicated by missed abortion, whereas postnatal patients showed predominant neurodevelopmental impairments. In our cohort, larger deletions were observed in cases presenting with more extensive multisystem involvement, a pattern that mirrors findings from recent large-cohort studies. central nervous system abnormalities were predominantly linked to SHANK3 haploinsufficiency, while multi-system malformations seemed to correlate with the cumulative loss of multiple genes across the 22q13 region, in keeping with current hypotheses on contiguous gene effects. Conclusions: PMS presents obvious prenatal–postnatal phenotypic heterogeneity. SHANK3 is the core pathogenic gene, and deletion may influence the extent of multisystem involvement. Combined genetic testing can improve the accuracy of prenatal diagnosis and counseling for PMS.Keywords
Funding Information
- Fujian Provincial Natural Science Foundation of China (2022J01421)
This publication has 39 references indexed in Scilit:
- Updated consensus guidelines on the management of Phelan–McDermid syndromeAmerican Journal of Medical Genetics Part A, 2023
- Definition and clinical variability of SHANK3-related Phelan-McDermid syndromeEuropean Journal of Medical Genetics, 2023
- Long-term trends in the incidence of congenital anomalies in Central China from 1997 to 2019Public Health, 2022
- Genotype–phenotype correlation in Phelan‐McDermid syndrome: A comprehensive review of chromosome 22q13 deleted genesAmerican Journal of Medical Genetics Part A, 2021
- Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification frameworkGenetics in Medicine, 2018
- Visualizing Genomic Data Using Gviz and Bioconductor2016
- Interstitial 22q13 deletions not involving SHANK3 gene: A new contiguous gene syndromeAmerican Journal of Medical Genetics Part A, 2014
- The emerging role of SHANK genes in neuropsychiatric disordersDevelopmental Neurobiology, 2013
- Automated comparative protein structure modeling with SWISS‐MODEL and Swiss‐PdbViewer: A historical perspectiveElectrophoresis, 2009
- Interstitial 22q13 deletions: genes other than SHANK3 have major effects on cognitive and language developmentEuropean Journal of Human Genetics, 2008